13F HOLDINGS REPORT
Sofinnova Investments, Inc.
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0001104659-23-091230
Total Value
$1.53B
Positions
55
Other Managers
0
Confidential Omitted
No
Holdings (55)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Karuna Therapeutics Inc | 48576A100 | 1,380,466 | $299.4M | 19.61% |
| 2 | Natera Inc | NTRA | 3,100,560 | $150.9M | 9.88% |
| 3 | AstraZeneca PLC | AZN | 1,697,517 | $121.5M | 7.96% |
| 4 | Intuitive Surgical Inc | ISRG | 201,182 | $68.8M | 4.51% |
| 5 | Ascendis Pharma A/S | ASND | 754,032 | $67.3M | 4.41% |
| 6 | Aerovate Therapeutics Inc | 008064107 | 3,758,686 | $64.5M | 4.22% |
| 7 | Merck & Co Inc | MRK | 527,373 | $60.9M | 3.99% |
| 8 | Vera Therapeutics Inc | VERA | 3,467,156 | $55.6M | 3.64% |
| 9 | Vertex Pharmaceuticals Inc | VRTX | 145,300 | $51.1M | 3.35% |
| 10 | Exelixis Inc | EXEL | 2,560,738 | $48.9M | 3.21% |
| 11 | Dexcom Inc | DXCM | 370,720 | $47.6M | 3.12% |
| 12 | IDEXX Laboratories Inc | 45168D104 | 70,674 | $35.5M | 2.32% |
| 13 | Immatics NV | IMTX | 3,041,487 | $35.1M | 2.30% |
| 14 | Syndax Pharmaceuticals Inc | SNDX | 1,582,291 | $33.1M | 2.17% |
| 15 | Boston Scientific Corp | BSX | 608,861 | $32.9M | 2.16% |
| 16 | Reata Pharmaceuticals Inc | 75615P103 | 322,471 | $32.9M | 2.15% |
| 17 | Cytokinetics Inc | CYTK | 843,228 | $27.5M | 1.80% |
| 18 | Inhibrx Inc | INBX | 998,283 | $25.9M | 1.70% |
| 19 | Zentalis Pharmaceuticals Inc | ZNTL | 828,005 | $23.4M | 1.53% |
| 20 | Inozyme Pharma Inc | 45790W108 | 3,655,308 | $20.4M | 1.33% |
| 21 | Geron Corp | GERN | 5,429,155 | $17.4M | 1.14% |
| 22 | Baxter Intl Inc | 071813109 | 362,200 | $16.5M | 1.08% |
| 23 | IDEAYA Biosciences Inc | IDYA | 664,746 | $15.6M | 1.02% |
| 24 | ImmunoGen Inc | 45253H101 | 827,318 | $15.6M | 1.02% |
| 25 | argenx SE | ARGX | 39,921 | $15.6M | 1.02% |
| 26 | Y-mAbs Therapeutics Inc | 984241109 | 2,194,278 | $14.9M | 0.98% |
| 27 | Revolution Medicines Inc | RVMDW | 520,377 | $13.9M | 0.91% |
| 28 | Axsome Therapeutics Inc | AXSM | 179,242 | $12.9M | 0.84% |
| 29 | Vir Biotechnology Inc | VIR | 488,117 | $12.0M | 0.78% |
| 30 | PTC Therapeutics Inc | PTCT | 260,443 | $10.6M | 0.69% |
| 31 | Marinus Pharmaceuticals Inc | 56854Q200 | 962,619 | $10.5M | 0.68% |
| 32 | Galera Therapeutics Inc | GRTX | 3,083,712 | $9.6M | 0.63% |
| 33 | Replimune Group Inc | REPL | 348,889 | $8.1M | 0.53% |
| 34 | Agenus Inc | AGEN | 4,909,132 | $7.9M | 0.51% |
| 35 | Vir Biotechnology Inc | VIR | 300,000 | $7.4M | 0.48% |
| 36 | Celldex Therapeutics Inc | CLDX | 197,758 | $6.7M | 0.44% |
| 37 | Dyne Therapeutics Inc | DYN | 441,048 | $5.0M | 0.32% |
| 38 | Nextcure Inc | NXTC | 2,671,856 | $4.8M | 0.32% |
| 39 | Nucana PLC | NCNA | 5,599,999 | $4.4M | 0.29% |
| 40 | Bolt Biotherapeutics Inc | BOLT | 2,754,437 | $3.5M | 0.23% |
| 41 | Marinus Pharmaceuticals Inc | 56854Q200 | 200,000 | $2.2M | 0.14% |
| 42 | Nucana PLC | NCNA | 2,400,000 | $1.9M | 0.12% |
| 43 | FibroGen Inc | 31572Q808 | 637,567 | $1.7M | 0.11% |
| 44 | PDS Biotechnology Corp | PDSB | 142,635 | $717,454 | 0.05% |
| 45 | FibroGen Inc | 31572Q808 | 250,000 | $675,000 | 0.04% |
| 46 | FibroGen Inc | 31572Q808 | 250,000 | $675,000 | 0.04% |
| 47 | FibroGen Inc | 31572Q808 | 250,000 | $675,000 | 0.04% |
| 48 | Fusion Pharmaceuticals Inc | 36118A100 | 117,099 | $546,852 | 0.04% |
| 49 | FibroGen Inc | 31572Q808 | 150,000 | $405,000 | 0.03% |
| 50 | Savara Inc | SVRA | 96,248 | $307,512 | 0.02% |
| 51 | Allakos Inc | 01671P100 | 62,465 | $272,347 | 0.02% |
| 52 | Synlogic Inc | SYBX | 574,972 | $247,238 | 0.02% |
| 53 | Mirum Pharmaceuticals Inc | MIRM | 9,089 | $235,132 | 0.02% |
| 54 | Karuna Therapeutics Inc | 48576A100 | 683 | $148,109 | 0.01% |
| 55 | Spruce Biosciences Inc | SPRB | 58,029 | $124,762 | 0.01% |